Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Briacell Therapeutics Corp (NQ: BCTX ) 0.9645 -0.1555 (-13.88%) Streaming Delayed Price Updated: 3:59 PM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 206,234 Open 1.130 Bid (Size) 0.9600 (31) Ask (Size) 0.9900 (2) Prev. Close 1.120 Today's Range 0.9500 - 1.130 52wk Range 0.9500 - 7.590 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024 June 14, 2024 BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 28, 2024 Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! Via InvestorPlace Performance YTD -81.94% -81.94% 1 Month -29.60% -29.60% 3 Month -62.03% -62.03% 6 Month -81.42% -81.42% 1 Year -85.18% -85.18% More News Read More Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 21, 2024 Via InvestorPlace BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 March 19, 2024 Via InvestorPlace BriaCell: An Emerging Immuno - Oncology Company August 14, 2023 Via Talk Markets Exposures Product Safety New Treatments May Help Those With Advanced Breast Cancer Live Longer April 17, 2023 Via StatePoint Media Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer February 08, 2023 Via Talk Markets Get Rich Quick With These 3 Penny Stocks to Buy Now February 12, 2024 Via InvestorPlace Topics Economy Exposures Economy BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients December 20, 2023 Via Benzinga Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023 September 13, 2023 Via FinancialNewsMedia Exposures Product Safety BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 31, 2023 Via NewMediaWire BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 30, 2023 Via TheNewswire.com BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 30, 2023 Via NewMediaWire Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer March 24, 2023 Via FinancialNewsMedia BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers January 18, 2023 Via Talk Markets BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer January 18, 2023 Via Talk Markets BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 Via News Direct Topics Death Exposures Death BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 Via TheNewswire.com Topics Death Exposures Death BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 13, 2022 Via Benzinga BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 02, 2022 Via TheNewswire.com Topics Stocks Exposures Product Safety US Equities BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 02, 2022 Via News Direct Exposures Product Safety BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 01, 2022 Via Benzinga IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies November 30, 2022 From ImmunoPrecise Antibodies Via Business Wire Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday September 20, 2022 Via Benzinga Why Is BriaCell (BCTX) Stock Moving Today? April 13, 2022 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
